إعلان
إعلان
NAGE
Niagen Bioscience, Inc. Common Stock
6.52
USDبرعاية
-0.03
-0.53%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
6.56
+0.04
+0.61%
تقارير أرباح NAGE
النسبة الإيجابية المفاجئة
NAGE تفوق 20 من 36 آخر التقديرات.
56%
التقرير التالي
بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$32.34M
/$0.02
التغير الضمني من Q3 25 (Revenue/ EPS)
-4.85%
/-60.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+11.04%
/-77.78%
Niagen Bioscience, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, NAGE reported earnings of 0.05 USD per share (EPS) for Q3 25, beating the estimate of 0.01 USD, resulting in a 206.75% surprise. Revenue reached 33.99 مليون, compared to an expected 31.72 مليون, with a 7.13% difference. The market reacted with a -1.01% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of 0.02 USD, with revenue projected to reach 32.34 مليون USD, implying an نقصان of -60.00% EPS, and نقصان of -4.85% in Revenue from the last quarter.
الأسئلة الشائعة
What were Niagen Bioscience, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Niagen Bioscience, Inc. Common Stock reported EPS of $0.05, beating estimates by 206.75%, and revenue of $33.99M, 7.13% above expectations.
How did the market react to Niagen Bioscience, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.01%, changed from $6.95 before the earnings release to $6.88 the day after.
When is Niagen Bioscience, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
What are the forecasts for Niagen Bioscience, Inc. Common Stock's next earnings report?
Based on 7
المحللين, Niagen Bioscience, Inc. Common Stock is expected to report EPS of $0.02 and revenue of $32.34M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان